Core Laboratories Inc.
NLFinancials
Valuation Metrics
Core Laboratories Inc.'s Market Cap is $525M. At end of 2025 it was $745M. Ranked #2781 of 3,121 in US market (top 89%), #1568 of 1,658 on NYSE (top 95%), #166 of 173 in Energy (top 96%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $525M | US#2,781/3,121 Sec#166/173 |
| Revenue | $519M | US#2,237/3,121 Sec#145/173 |
| Net Income | $24M | US#2,074/3,121 Sec#129/173 |
| Total Assets | $587M | US#2,706/3,121 Sec#168/173 |
| Net Assets | $273M | US#2,571/3,121 Sec#160/173 |
| Employees | 3,300 | US#1,433/3,121 Sec#63/173 |
| Value | ||
| P/E | 21.56x | US#1,224/3,121 Sec#92/173 |
| P/B | 1.93x | US#1,190/3,121 Sec#78/173 |
| P/S | 1.01x | US#703/3,121 Sec#39/173 |
| EV/EBITDA | 10.65x | US#918/3,121 Sec#108/173 |
| FCF Yield | 2.04% | US#2,033/3,121 Sec#128/173 |
| Profitability | ||
| ROE | 8.93% | US#1,492/3,121 Sec#104/173 |
| ROA | 4.15% | US#1,205/3,121 Sec#94/173 |
| Op. Margin | 9.25% | US#1,663/3,121 Sec#119/173 |
| Revenue Growth | 0.35% | US#2,228/3,121 Sec#131/173 |
| Earnings Growth | -17.81% | US#1,534/3,121 Sec#95/173 |
| Financial Health | ||
| Debt Ratio | 112.96% | US#1,216/3,121 Sec#81/173 |
| Total Debt | $165M | US#2,308/3,121 Sec#153/173 |
| FCF | $11M | US#2,237/3,121 Sec#136/173 |
| Cash | $23M | US#2,839/3,121 Sec#153/173 |
| Current Ratio | 2.12x | US#1,170/3,121 Sec#50/173 |
| Net Debt/EBITDA | 2.27x | US#1,403/3,121 Sec#106/173 |
| Dividend | ||
| Div. Yield | 0.35% | US#1,586/3,121 Sec#127/173 |
| Div. Growth | 0.50% | US#1,192/3,121 Sec#75/173 |
| Payout Ratio | 5.88% | US#2/3,121 Sec#1/173 |
| Performance | ||
| 1Y Return | -8.73% | US#2,079/3,121 Sec#155/173 |
| 1M Return | -9.03% | US#2,337/3,121 Sec#156/173 |
| From 52W High | -44.06% | US#2,572/3,121 Sec#162/173 |
| 1Y MDD | -49.82% | US#2,453/3,121 Sec#159/173 |
| Trading | ||
| Volume | 503,725 shares | US#2,015/3,121 Sec#130/173 |
| Trading Value | $6M | US#2,605/3,121 Sec#156/173 |
| Per Share | ||
| EPS | $0.53 | US#1,876/3,121 Sec#116/173 |
| BPS | $5.92 | US#2,201/3,121 Sec#131/173 |
Company Info
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.